Human tumor necrosis factor-α mutant RGD-V29 (F4614) shows potent antitumor activity and reduced toxicity against human tumor xenografted nude mice
- 6 September 2000
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 159 (1) , 33-41
- https://doi.org/10.1016/s0304-3835(00)00529-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Preferential Activity of Wild‐type and Mutant Tumor Necrosis Factor‐α against Tumor‐derived Endothelial‐like CellsJapanese Journal of Cancer Research, 2000
- A novel human tumor necrosis factor alfa mutein, F4614, inhibits in vitro and in vivo growth of murine and human hepatoma: Implication for immunotherapy of human hepatocellular carcinomaHepatology, 1998
- Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell DeathCell, 1996
- An Essential Role for NF-κB in Preventing TNF-α-Induced Cell DeathScience, 1996
- Novel muteins of human tumor necrosis factor with potent antitumor activity and less lethal toxicity in miceInternational Journal of Cancer, 1995
- Novel Mutein of Tumor Necrosis Factor α (F4614) with Reduced Hypotensive EffectJournal of Interferon & Cytokine Research, 1995
- Overcoming the Metastasis-Enhancing Potential of Human Tumor Necrosis Factor α by Introducing the Cell-Adhesive Arg-Gly-Asp SequenceJournal of Interferon & Cytokine Research, 1995
- A novel domain within the 55 kd TNF receptor signals cell deathCell, 1993
- Four different interleukin-1 species sensitize to the lethal action of Tumour Necrosis FactorBiochemical and Biophysical Research Communications, 1989
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986